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Abstract
Background: Nitric oxide plays an important role in the regulation of male and female sexual
behavior in rodents, and the expression of the nitric oxide synthase (NOS) is influenced by
testosterone in the male rat, and by estrogens in the female. We have here quantitatively
investigated the distribution of nNOS immunoreactive (ir) neurons in the limbic hypothalamic
region of intact female mice sacrificed during different phases of estrous cycle.
Results: Changes were observed in the medial preoptic area (MPA) (significantly higher number
in estrus) and in the arcuate nucleus (Arc) (significantly higher number in proestrus). In the
ventrolateral part of the ventromedial nucleus (VMHvl) and in the bed nucleus of the stria
terminalis (BST) no significant changes have been observed. In addition, by comparing males and
females, we observed a stable sex dimorphism (males have a higher number of nNOS-ir cells in
comparison to almost all the different phases of the estrous cycle) in the VMHvl and in the BST
(when considering only the less intensely stained elements). In the MPA and in the Arc sex
differences were detected only comparing some phases of the cycle.
Conclusion: These data demonstrate that, in mice, the expression of nNOS in some hypothalamic
regions involved in the control of reproduction and characterized by a large number of estrogen
receptors is under the control of gonadal hormones and may vary according to the rapid variations
of hormonal levels that take place during the estrous cycle.
Background
Nitric oxide (NO) is a messenger molecule, synthesized
from arginine by a family of three distinct nitric oxide syn-
thase (NOS) isoforms: (a) neuronal NOS (nNOS or NOS
type I); (b) endothelial NOS (eNOS or NOS type III) that
are Ca2+ dependent; (c) macrophagical NOS (mNOS or
NOS type II) that is Ca2+ independent [1,2]. The neuronal
isoform of this enzyme (nNOS), is regulated by several
cofactors including calmodulin, and reduced nicotina-
mide adenine dinucleotide phosphate (NADPH) [3].
The NO system is implicated in the control of many
behaviors [4]. In particular, several studies suggest that
NO might facilitate the expression of rodents' sexual
behavior in both sexes, at peripheral and central levels,
probably through its action on specific neurotransmitter
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by eNOS and nNOS is involved in several tasks as the reg-
ulation of penile erection [6], ovulation [7,8] or transfer
of oocytes from the ovaries to the oviducts [9]. Centrally,
NO has an important role in controlling male and female
sexual behavior [10-13]. This has been confirmed by the
use of different lines of knockout mice. In particular the
disruption of the exon 2 (resulting in residual nNOS activ-
ity due to the expression of alternatively spliced RNA
forms) induces an improper sexual behavior [14],
whereas the disruption of exon 6 (resulting in the total
loss of nNOS activity) induces the disappearance of male
sexual behavior and female ovulation [15]. Finally, NO
promotes the release of gonadotropin releasing factor
(GnRH) [16-18].
The control of reproductive behavior by NO is mediated
at central level, by interactions with other neurotransmit-
ter systems (for reviews see [19-21]). For instance, testo-
sterone (T), in male rats, increases NO levels, through its
action on nNOS. In the medial preoptic area (MPA), NO
stimulates the release of dopamine (DA) that, in turn, pro-
motes copulation [22]. The action on nNOS is mediated
by the aromatization of T into 17β-estradiol (E2) and not
by the reduction to dihydrotestosterone (DHT) [23].
Moreover, the NO-cGMP system is part of an intracellular
signaling pathway to regulate the facilitatory effect of α1-
adrenoreceptors on lordosis behavior in female rats (for a
review see [24]).
A correlation between serotonin and NO is demonstrated
by the partial alteration of the serotonin metabolism in
mice lacking nNOS gene [25] and by the action of NO as
a mediator of the stimulatory effects of serotonin in the
MPA on luteinizing hormone secretion [26].
The presence of NO-producing neurons has been
described in detail by means of histochemistry for
NADPH-diaphorase, nNOS immunohistochemistry, and
in situ hybridization, in numerous areas of the vertebrate
central nervous system [27-34]. In the rat, the distribution
of nNOS positive cells has been detailed in particular in
hypothalamic and limbic nuclei involved in the control of
the reproductive behavior: e.g., MPA, paraventricular
(PVN), supraoptic (SON), arcuate (Arc) and ventromedial
nucleus (VMH), bed nucleus of the stria terminalis (BST)
[35-37], medial amygdala (MeA) and bed nucleus of the
accessory olfactory tract (BAOT) [38,39].
Several studies in rodents show that, in these regions,
nNOS expression is regulated by gonadal hormones. Cas-
tration decreases and treatment with T or its metabolite E2
increases the number of nNOS- or NADPH-diaphorase-
positive cells, as well as the expression of mRNA for nNOS
in MPA, PVN and ventrolateral part of the ventromedial
nucleus (VMHvl) ([23,40-44]; for a complete biblio-
graphic review see [5]).
The fundamental role of E2 and of estrogen receptors
(ERs) in regulating/differentiating the nNOS system is
also confirmed by our preliminary results obtained in
mutant mice that either lacked the ERα receptor or were
not exposed to E2 (aromatase knockout, ArKO) male
mice. In both cases we detected a significant decrease of
nNOS immunoreactivity in the MPA, PVN and Arc [45].
Moreover it has been shown that ERα and AR interact to
regulate nNOS in male and female brain in a site-specific
manner [46]. NADPH-diaphorase activity enhances dur-
ing the estrus phase in the BAOT [39] and MeA [38] of
female rat.
To further clarify the interrelationships between NO and
gonadal hormones, we investigated here the effects of the
estrous cycle on the expression of nNOS immunoreactiv-
ity in the hypothalamic and limbic system of female mice,
with a focus on nuclei involved in the control of reproduc-
tion. In addition we have compared the distribution of
nNOS immunoreactivity between male and female mice,
in order to verify the presence of sexual dimorphism.
Results
Qualitative analysis
The pattern of distribution of nNOS immunoreactive cells
within the limbic-hypothalamic region of male mice was
according to previous observations in rodents [30,32] and
it is summarized in Figs 1 and 2.
At the level of the anterior commissure (CA) a large
number of positive neurons are found in the periventricu-
lar (AvPe) region and in the MPA ventral portion, close to
the third ventricle. In the dorsal portion of MPA, only scat-
tered, intensely stained neurons are present (Fig. 1A).
They have a clear nucleus and an extended dendritic
arborization. More caudally within the MPA, the nNOS-
positive neurons are denser in the medial region than in
the lateral, where, on the contrary, several positive fibers
are present (Figs 1C, 3B).
A relevant group of nNOS-ir cells was observed in the BST,
mainly clustered within its ventromedial subdivision
(BSTmv); these cells were small, round, intensely or
weakly stained with a relatively large nucleus (Figs 1C, 3B,
Fig. 5).
A large number of intensely stained neurons are present in
the PVN: these cells are mainly located in the dorsal part
of the nucleus (Figs 1E, F, 2A, 3C), a large number of pos-
itive cells is located laterally to the PVN around the fornix.
A cluster of intensely stained neurons is present also at the
level of the supraoptic nucleus (Fig. 1E).Page 2 of 14
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A-F. Six drawings corresponding to coronal sections through a representative male mouse hypothalamus and limbic system arranged from the most r stral (A – p eoptic area) to the most caudal (F – paraventric lar region)Figur  1
A-F. Six drawings corresponding to coronal sections through a representative male mouse hypothalamus and 
limbic system arranged from the most rostral (A – preoptic area) to the most caudal (F – paraventricular 
region). Grey dots illustrate the distribution of nNOS-ir cell bodies. Nuclei are delineated according to the mouse brain atlas 
[69]. aca = anterior commissure, anterior; acp = anterior commissure, posterior; Arc = arcuate nucleus; AVPe = anteroventral 
periventricular nucleus; BSTmpm = bed nucleus of the stria terminalis, posteromedial subdivision; BSTmv = bed nucleus of the 
stria terminalis, ventromedial subdivision; DM = dorsomedial hypothalamic nucleus; f = fornix; LA = lateroanterior hypotha-
lamic nucleus; mfb = medial forebrain bundle; ME = median eminence; MPA = medial preoptic area; opt = optic tract; ox = 
optic chiasm; PaAP = anterior parvicellular part of PVN; PaLM = lateral magnocellular part of PVN; PaV = ventral part of PVN; 
PVN = paraventricular nucleus; SCh = suprachiasmatic nucleus; VMH = ventromedial nucleus; VMHdm = ventromedial nucleus, 
dorsomedial part; VMHc = ventromedial nucleus, central part; VMHvl = ventromedial nucleus, ventrolateral part; * = third ven-
tricle.
BMC Neuroscience 2009, 10:78 http://www.biomedcentral.com/1471-2202/10/78
Page 4 of 14
(page number not for citation purposes)
A-F. Six drawings corresponding to coronal sections through a representative male mouse hypothalamus and limbic system arranged from the most r stral (A – paraventricular region) to the most caudal (F – p st rior region)Figur  2
A-F. Six drawings corresponding to coronal sections through a representative male mouse hypothalamus and 
limbic system arranged from the most rostral (A – paraventricular region) to the most caudal (F – posterior 
region). Grey dots illustrate the distribution of nNOS-ir cell bodies. Nuclei are delineated according to the mouse brain atlas 
[69]. aca = anterior commissure, anterior; acp = anterior commissure, posterior; Arc = arcuate nucleus; AVPe = anteroventral 
periventricular nucleus; BSTmpm = bed nucleus of the stria terminalis, posteromedial subdivision; BSTmv = bed nucleus of the 
stria terminalis, ventromedial subdivision; DM = dorsomedial hypothalamic nucleus; f = fornix; LA = lateroanterior hypotha-
lamic nucleus; mfb = medial forebrain bundle; ME = median eminence; MPA = medial preoptic area; opt = optic tract; ox = 
optic chiasm; PaAP = anterior parvicellular part of PVN; PaLM = lateral magnocellular part of PVN; PaV = ventral part of PVN; 
PVN = paraventricular nucleus; SCh = suprachiasmatic nucleus; VMH = ventromedial nucleus; VMHdm = ventromedial nucleus, 
dorsomedial part; VMHc = ventromedial nucleus, central part; VMHvl = ventromedial nucleus, ventrolateral part; * = third ven-
tricle.
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present in VMH and Arc nuclei. Within the VMH,
intensely stained neurons are only present in the ventrola-
teral part of the nucleus (VMHvl, Figs. 2C, D, E, F). The
other sub-regions of the nucleus are intensely stained due
to the presence of a high number of positive fibers. In the
Arc, round and weakly stained cell bodies are present in
the whole extension of the nucleus (Figs. 2C, D, E, F, 3D).
Scattered intensely positive cells are also present in the
dorsal hypothalamic nucleus.
The observation of female mice taken at different stages of
the estrous cycle evidenced a similar pattern of distribu-
tion, but at the same time suggested the existence of pro-
nounced variations in cell number. Also the comparison
with males evidenced some difference (Figs. 4, 5, and 6).
To confirm these observations, we performed a quantita-
tive analysis of the nNOS-ir elements.
Quantitative analysis
The results of the quantitative analysis are summarized in
Figs. 4, 5, and 6 [see also Additional File 1].
Medial preoptic area (MPA)
In the MPA, the preliminary 2-way mixed ANOVA
revealed not significant effect of the interaction among the
cycle phases and the levels, therefore anterior-posterior
levels were collapsed and the mean values of nNOS-ir cell
number were analyzed by a one-way ANOVA. In this case,
we found a statistically significant effect of the phase on
the nNOS positive cell number (F[4,20] = 6.52; p = 0.002).
The post-hoc Fisher PLSD test showed a significant
decrease of positive cell number in proestrus (p = 0.004)
and diestrus (p = 0.003) in comparison to estrus. Moreo-
ver, males had a higher number of positive cells than
females in all the estrous phases with the exception of
estrus (p = 0.001 for comparison with proestrus, p < 0.001
for comparison with diestrus, p = 0.04 for comparison
with metestrus) (Fig. 4).
Micrographs illustrating the nuclei considered in the experi-mentFigure 3
Micrographs illustrating the nuclei considered in the 
experiment. Boxed areas represent the regions in which 
nNOS-ir cells were quantified. Scale bar: 200 μm. Distribution of nNOS-ir neurons within the mouse medial preoptic area (MPA)Figure 4Distribution of nNOS-ir neurons within the mouse 
medial preoptic area (MPA). Comparison among females 
in different stages of the cycle (estrus and diestrus) and 
males. Scale bar: 150 μm. The histogram reports the quanti-
tative differences in the number of nNOS-ir cells (mean ± 
standard error). * = p < 0.05 in comparison to males; °° = p 
< 0.01 in comparison to estrus female.Page 5 of 14
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posteromedial subdivisions (BSTmv and BSTmpm)
In the posteromedial subdivision of the BST (BSTmpm),
as well as in the ventromedial subdivision of the BST
(BSTmv), the preliminary 2-way mixed ANOVA revealed
not significant effect of the interaction among the cycle
phases and the levels, and the following one-way ANOVA
on the mean values of nNOS-ir cell number was also not
significant.
However, we observed in both BSTmpm and BSTmv the
presence of positive cells with a different intensity of
immunostaining, that we have therefore classified as clear
or dark positive elements. The one-way ANOVA for both
clear and dark cells within the BSTmpm reported not sig-
nificant differences for the cycle phase. A similar result
was obtained with the one-way ANOVA for dark cells in
the BSTmv. On the contrary, the one-way ANOVA for the
number of clear nNOS-positive cells within the BSTmv
reported a significant effect of cycle phase (F[4,20] = 4.03, p
= 0.015). The Fisher PLSD test revealed that this effect is
due to a higher number of positive clear cells in males in
comparison to females in proestrus (p = 0.002), estrus (p
= 0.027), and diestrus (p = 0.002) (Fig. 5).
Arcuate nucleus (Arc)
In the Arc the preliminary 2-way mixed ANOVA revealed
not significant effect of the interaction among the cycle
phases and the levels, therefore anterior-posterior levels
were collapsed and the mean values of nNOS-ir cell
number were analyzed by a one-way ANOVA. In this case,
we found a statistically significant effect of the cycle on the
nNOS positive cells number (F[4,20] = 7.04, p = 0.001). The
post-hoc Fisher PLSD test showed that proestrus and
estrus have significantly higher numbers of positive cells
than diestrus and metestrus (p = 0.0032 and p = 0.0001
for the comparison of proestrus versus metestrus and die-
strus respectively; p = 0.0022 for the comparison of estrus
versus diestrus). In addition, males showed significantly
fewer positive cells than proestrous females (p = 0.021),
and a significantly higher number of positive cells than
diestrous females (p = 0.027) (Fig. 6).
Ventromedial nucleus, ventrolateral part (VMHvl)
In the VMHvl the 2-way mixed ANOVA showed a signifi-
cant effect of the interaction among the cycle phases and
the levels (F[1,4] = 3.65, p = 0.022). Therefore, we per-
formed the one way-ANOVA for each level. No effect of
the phase was observed for the more rostral level (F[4,20] =
0.77, p = 0.55). On the contrary the one-way ANOVA for
the more caudal level reported a value of p close to signif-
icance (F[4,20] = 2.55, p = 0.07). We have therefore applied
the Fisher PLSD test, that reported significant differences
in the number of positive cells among males and
proestrous (p = 0.035), metestrous (p = 0.025) and
diestrous females (p = 0.008), due to a higher number of
positive cells in males in comparison to females.
Paraventricular nucleus (PVN) and Caudate-Putamen
No significant variations were detected in the PVN [7]or
CPu during estrous cycle nor in the comparison male-
female [see Additional File 1].
Discussion
Present data show that during the estrous cycle the expres-
sion of nNOS may significantly vary in some limbic-
hypothalamic nuclei. Statistically significant changes in
the nNOS-ir cells number were observed only in MPA and
Arc, whereas in the other nuclei (e.g., PVN, BSTmpm,
BSTmv and VMHvl) the NOS-ir cells number does not
show significant changes during the different stages of the
estrous cycle. Moreover, changes in the number of nNOS-
Distribution of weakly stained (clear) nNOS-ir neurons w thin the m use bed nucleus of the stria terminalis, ventro-med al subdivision (BSTmv)Figure 5
Distribution of weakly stained (clear) nNOS-ir neu-
rons within the mouse bed nucleus of the stria termi-
nalis, ventromedial subdivision (BSTmv). Comparison 
among females and males. Scale bar: 150 μm. The histogram 
reports the quantitative differences in the number of nNOS-
ir cells (mean ± standard error). * = p < 0.05 in comparison 
to males.Page 6 of 14
(page number not for citation purposes)
BMC Neuroscience 2009, 10:78 http://www.biomedcentral.com/1471-2202/10/78ir cells in MPA and Arc do not follow the same pattern. In
MPA, the highest number of positive neurons was
detected during estrus, whereas in proestrus and diestrus
we have the lower values. In Arc, the highest number of
nNOS-ir cells was detected in proestrus, while metestrus
and diestrus show the lower number of NOS-ir cells.
The comparison with males shows a stable sex dimor-
phism (males have a higher number of nNOS-ir cells in
comparison to almost all the different phases of the
estrous cycle) in the VMHvl and in the BSTmv (when con-
sidering only the less intensely stained elements, e.g.
probably the part of NO-producing population that is less
active). In MPA and Arc, sex differences were detected only
comparing some phases of the cycle. In both nuclei,
females in estrus have a number of positive cells that is
not significantly different with that of males.
The distribution of nNOS immunoreactive elements
within the limbic-hypothalamic region confirms previous
reports in both mice [30,47] and rats [32]. Major clusters
of NO-producing neurons are present within the preoptic
area, the BST, the PVN and the VMH; scattered positive
elements are present in the Arc nucleus. All these regions
show, in mice, a large number of alpha and beta estrogen
receptors (ER) [48,49], progesterone receptors (PR) [50],
and androgen receptors (AR) [51], therefore confirming
the idea that gonadal hormones may modulate the
expression of nNOS [5].
Distribution of nNOS-ir neurons within the mouse arcuate nucleus (Arc)Figure 6
Distribution of nNOS-ir neurons within the mouse arcuate nucleus (Arc). Comparison among females in different 
stages of the cycle (proestrus and diestrus) and males. Scale bar: 150 μm. The histogram reports the quantitative differences in 
the number of nNOS-ir cells (mean ± standard error). * = p < 0.05 in comparison to males; °° = p < 0.01 in comparison to 
estrus female; ^^ = p < 0.01 in comparison to proestrus females.Page 7 of 14
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As reported in the introduction, the majority of previous
experimental studies have been performed after long
exposure to high levels of gonadal hormones (in particu-
lar testosterone or estradiol) [40,52] and only a few stud-
ies have addressed if and how nNOS expression is
physiologically regulated. In particular, the nNOS system
of some telencephalic nuclei of the accessory olfactory
pathway (bed nucleus of the accessory olfactory tract and
anteroventral subdivision of the medial amygdala) shows
a significant increase in NADPH-diaphorase positive cell
number in estrous females in comparison to diestrous
ones [38,39]. Also the levels of cGMP (NO second mes-
senger) are influenced by the estrous cycle: the release of
cGMP in the MPA increases in the proestrus and diestrus
afternoon in female rats [53].
In the present study, two hypothalamic nuclei related to
the control of reproduction (MPA and Arc) show varia-
tions in the nitrinergic neuronal population during the
estrous cycle. However, in the same phase of the cycle, the
proestrus (when the estrogens reach their peak), we
observed the highest level of positive elements in Arc and
the lowest in MPA. The NO system of the MPA is target for
the action of gonadal hormones also in males; in fact
long-term castration induces a decrease, and treatment
with testosterone induces an increase in the number of
nNOS-ir cells in male rats [41] and male Syrian hamsters
[42].
In the other investigated nuclei (i.e., PVN, VMHvl,
BSTmpm, BSTmv), even though a large amount of estro-
gen receptors are expressed, we have not observed any sig-
nificant change in the NOS-ir distribution during the
female estrous cycle. The lack of effects in the PVN is par-
Distribution of nNOS-ir neurons within the mouse paraventricular nucleus (PVN)Figure 7
Distribution of nNOS-ir neurons within the mouse paraventricular nucleus (PVN). Comparison among females in 
different stages of the cycle (proestrus and metestrus) and males. Scale bar: 150 μm. The histogram reports the mean number 
of nNOS-ir cells (mean ± standard error) per each examined stage.Page 8 of 14
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documented changes in the expression of nNOS or
NADPH-diaphorase following changes in E2 availability.
Administration of E2 increases the number of NADPH-
diaphorase positive cells in male rats [43], whereas ERα
KO or ArKO male mice showed a significant decrease in
NOS-ir cell number in PVN [54,55]. One obvious remark
is that the studies referred to were performed in males,
while data in females that lack ER or aromatase (KO mice)
or have constant exogenous E2, do not show significant
hormonal regulation of NADPH-diaphorase [43]. In addi-
tion, the use of NAPDH-diaphorase histochemistry for the
identification of nNOS system can introduce some dis-
crepancies. In fact, both in the rat hypothalamus [56] and
in the mouse basal forebrain [57] the number of nNOS-ir
cells was higher than that of NADPH-diaphorase positive
elements.
A second important remark is that, in the female, even the
short-term treatment of ovariectomized individuals (an
experimental situation that should emulate the estrus)
results in an exposure to high levels of E2 for several days,
while the natural conditions during the estrous cycle is
that the peak of E2 is lasting only for a few hours, therefore
the experimental simulation is probably overstimulating
the system. In our opinion, this explains the lack of
changes that we have observed at the level of VMH during
the cycle, in contrast to the significant increase of nNOS
mRNA in VMH [40,58] observed after short-term (2 days)
or long-term (8-days) E2-treatment of ovariectomized
female rats. We believe that this difference is the result of
the very short term and transient changes happening dur-
ing the estrous cycle compared to the effects of a longer
exposure. In addition, in these previous experiments the
effect of E2 only has been considered, whereas in natural
conditions, all the gonadal hormones (including proges-
terone) are changing.
Obviously, when such significant variations take place,
also the comparison with males may vary according to the
stage of the cycle. Therefore, in MPA sexual differences are
significant for proestrus, metestrus and diestrus (with the
nNOS expressing cells more numerous in males than in
females), suggesting the existence of activational effects,
rather than a stable dimorphism of this system. In Arc
proestrous and diestrous females have higher numbers of
NOS-ir elements in comparison with male mice.
Colocalization of NOS-ir elements with gonadal 
hormones' receptors
Estrogen, androgen and progesterone receptors co-local-
ize with nNOS in rodent hypothalamus, however differ-
ent studies evidenced different degrees of co-existence in
rats and mice. In MPA 25–50% of nitrinergic elements
express ERα in male rat [59,60], and 90% of them in male
mouse [46]; whereas 50% of nNOS cells express AR in
male rat [60] and only 20% in male mouse [46]. In anter-
oventral periventricular nucleus 60% of nNOS cells are
co-localized with ERα, and 77% are co-localized with AR
in male rat [60]. In VMH about 90% of nitrinergic ele-
ments co-localize with ERα in male rat [59]. ERα co-local-
ize with 16% and AR with 6% of nNOS cells in BST, while
10% of nitrinergic neurons co-localize with ERα or AR in
PVN of male mouse [46]. Furthermore, nitrinergic ele-
ments and PR show a low degree of co-localization in the
MPA (6–16%) in comparison to VMH (55–57%) of the
guinea pig [44]. In addition, in MPA fluctuations of ERα
and PR expression accompany the hormonal events that
occur during the rat estrous cycle [61]. Summarizing,
these data suggest that ERα is an important factor to
induce the expression of nNOS within the limbic and
hypothalamic system, but, due to the differences in the co-
localization, its importance may vary among the different
nuclei of these regions. This is also confirmed by studies
using mice lacking ERα, AR or both [46,54] that demon-
strated that ERα may upregulate nNOS expression in a
nucleus-specific way.
Gonadal hormone-mediated control of nNOS expression
Present data and those reported in the literature clearly
indicate a relationship among changes of estrogen levels
and expression of nNOS, however, several problems are
still unsolved. At first, the majority of data presented in
the literature were taken in experiments involving one sex
(generally the male), and in very different hormonal con-
ditions (gonadectomy, short or long hormonal treatment,
genetic manipulations). In addition, the situation in the
rat could be strongly different from the mouse: about 50%
of nNOS neurons in male rat MPA colocalize with ERα
[60], whereas 90% of nitrinergic neurons co-localize in
male mouse MPA [46], and corresponding data are not
available for females of both species.
Examining our data, the most surprising feature is that the
apparent patterns of estrous cycle influences are not the
same across neuronal cell groups. We believe that a mul-
tifactorial hypothesis should be considered in order to
explain this fact. At first, as summarized before, different
nuclei have a different degree of co-localization among
nNOS cells and gonadal hormones' receptors. These dif-
ferences may determine the different degrees of stimula-
tion or depression of the nNOS system in the examined
nuclei.
Secondly, the expression of ERα across the estrous cycle
varies independently in the different hypothalamic nuclei
[62]. This has been observed in female rats, demonstrat-
ing that estrogen receptor mRNA levels vary during the
estrous cycle, but the magnitude and direction of change
observed during the cycle is region specific. This suggestsPage 9 of 14
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differentially modulate ER mRNA expression in the
hypothalamus. Among these factors, the selective estro-
gen receptor modulators (SERMs) may have a prominent
role. For example, some nuclear receptor co-activators, as
the Steroid Receptor Coactivator-1 (SRC-1), control ER
and PR action in brain and affect distinct aspects of hor-
mone dependent sexual behaviors [63]. Moreover, SRC-1
expression change in a region-specific manner in the rat
brain during the estrous cycle [64]. This is also the case of
the transcription factor AP-2 [65,66].
In addition to an indirect role on the expression of nNOS,
through differentially regulating ER expression, SERMs
may have a direct influence as well. In fact, the promoters
of nNOS gene in mouse and in humans are regulated by
some of these SERMs or transcription factors. Thus, in
human nNOS gene the sequence inspection of 5'-flanking
regions revealed the presence of AP-2 [67], whereas the
steroidogenic factor 1 (SF-1), regulates nNOS gene expres-
sion in rat pituitary gonadotropes [68].
The functional implications of these changes in nNOS
immunoreactivity are probably as complex as the putative
mechanisms that are influencing them. In particular, sev-
eral studies demonstrated that higher levels of nNOS
imply an increased production of NO and the stimulation
of its intracellular signaling pathway culminating in an
increase of cGMP (for a review see [24]). Therefore, it is
possible that fluctuations in the amount of nNOS within
defined nuclei (MPA, ARC or, for a limited extent, BST)
may relate to activation/inactivation of NO signaling
pathway. Unfortunately, whereas a limited amount of
information about changes in cGMP levels around the
estrous cycle are available for female rat [53], similar data
are not known at this time for female mouse and, due to
the strong differences in co-localization of ERα and nNOS
in rats and mice (see before), it seems not viable to specu-
late that cGMP changes will appear in the same direction
also in female mouse. More experimental data are neces-
sary to understand how the hormonally induced changes
in nNOS may influence endocrine and/or behavioral
parameters.
Conclusion
In summary, the data collected in this study show and
confirm the presence of nitrinergic neurons in several
hypothalamic nuclei involved in the control of reproduc-
tive activity of male and female mice. In addition, we
demonstrated that in female mice there are at least two
populations of NO producing neurons, sensitive and
insensitive to gonadal hormones fluctuations during the
estrous cycle. The mechanisms of this differential, site-
specific, sensitivity are not clear, but probably are based
on the different pattern of distribution of AR, ER, and PR
and SERMs within the nNOS system.
Methods
Animals
A total of 25 mice (5 males and 20 females) were
employed in the study. We used a mouse strain, which
was previously obtained in our laboratory by crossing two
lines of mice: C57BL/6 and DBA2. Animals were housed,
in monosexual groups of five, in cages with free access to
food and water and maintained on a 12 h light 12 h dark
cycle at a temperature of 23 ± 2°C.
The females were inspected for the stage of the estrous
cycle (examination of a single vaginal smear) immediately
before the sacrifice, and they were divided into 4 groups
[proestrus (n = 5), estrus (n = 5), metestrus (n = 5), die-
strus (n = 5)], depending on the day of the cycle.
Animal care was in accordance with the European Com-
munity Council Directive of November 24, 1986 (86/
609/EEC), and the experimental protocol was approved
by the Ethical Committee of the University of Torino and
the Ministero dell'Università e della Ricerca Scientifica e
Tecnologica.
Fixation and tissue preparation
At the age of two months the mice were sacrificed using
anesthesia overdose and perfusion. The animals were sub-
jected to an anesthesia overdose (intraperitoneal injection
of tri-bromo-ethanol, 250 mg/kg), followed by trans-car-
diac perfusion of a saline solution (0.9%), until the return
blood was clear, and then of 150 ml of fixative [4% para-
formaldehyde in 0.1 M phosphate buffer (PB), pH 7.3–
7.4].
Brains were dissected out of the skull, post-fixed for 2 h at
4°C in the same fixative, and rinsed in 0.01 M phosphate
buffered saline (PBS). They were then placed overnight in
a 30% sucrose solution in PBS, frozen in liquid isopen-
tane at -35°C, and stored in a deep freezer at -80°C until
sectioning.
Brains were serially cut in the coronal planes at 25 μm
thickness with a cryostat. The plane of sectioning was ori-
ented to match the drawings corresponding to the coronal
sections of the mouse brain atlas [69]. Sections were col-
lected in a cryoprotectant solution [70] at -20°C. Every
fourth section (a section every 100 μm) one was processed
for nNOS immunohistochemistry after 24 h washing in
PBS. Adjacent sections were Nissl-stained with toluidine
blue, or used for controls. Brain sections obtained from
different experimental groups were stained simultane-
ously in order to reduce as much as possible between
assays variances.Page 10 of 14
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The sections were stained for nNOS by the avidin-biotin
method according to our standard procedure [30]. Briefly,
to block endogenous peroxidase activity, sections, col-
lected in multidish wells, were immersed in a solution of
methanol/hydrogen peroxide for 20 minutes. After wash-
ing, they were incubated overnight at room temperature
with an anti-nNOS rabbit antibody (DiaSorin, MN, USA,
diluted 1:12.000 in PBS, pH 7.3–7.4, containing 0.2% Tri-
ton X-100). The antigen-antibody reaction was revealed
by the biotin-avidin system (BAS, Vectastain Elite kit,
Labtek). The peroxidase activity was visualized with a
solution containing 0.15 mg/ml 3,3'-diamino-benzidine
(Sigma, Milano, Italy) and 0.025% hydrogen peroxide in
0.05 M Tris-HCl buffer pH 7.6. Sections were collected on
chromalum-coated slides, air-dried, washed in xylene and
coverslipped with Entellan (Merck, Milano, Italy).
The commercial antibody against nNOS was generated in
rabbit against a C-terminal synthetic peptide sequence
(1419–1433) of human nNOS. The manufacturer (dr. Jef-
frey Spangenberg, IncStar, Stillwater, MN) tested the spe-
cificity of the antibody by Western blot analysis and pre-
adsorption with synthetic human nNOS (5 mg per ml of
antibody at working dilution). No cross reactivity with
other forms of NOS was reported [71,72]. The nNOS
antiserum has been successfully used in human, rat,
mouse, cat and monkey tissue. In particular, the specifi-
city of this antibody for mouse central nervous tissue was
tested in nNOS knockout mice where cerebellar and amy-
gdala staining was totally abolished [73]. In our material,
we have performed the following controls: a) the primary
antibody was omitted or replaced with an equivalent con-
centration of normal serum (negative controls); b) the
secondary antibody was omitted. In these conditions,
cells and fibers were totally unstained.
Quantitative analysis
Quantification procedure was performed according to our
previously published method [74]. Briefly, in the present
study we assessed seven different limbic-hypothalamic
nuclei identified on the basis of the stereotaxic mouse
brain atlas [69]. For each animal two standardized sec-
tions of comparable levels per nucleus were examined:
medial preoptic area (MPA, corresponding to Bregma
0.02 mm and -0.10 mm), ventrolateral part of the ventro-
medial nucleus (VMHvl, corresponding to Bregma -1.46
mm and -1.58 mm), arcuate nucleus (Arc, corresponding
to Bregma -1.46 mm and -1.58 mm), posteromedial
(BSTmpm) and ventromedial (BSTmv) subdivision of the
bed nucleus of the stria terminalis (corresponding to
Bregma 0.02 mm and -0.10 mm), paraventricular nucleus
(PVN, corresponding to Bregma -0.58 mm; -0.82 mm; -
1.06 mm) and caudate-putamen nucleus (CPu, corre-
sponding to Bregma 0.02 mm, only one section exam-
ined).
For the analysis of the PVN nNOS-ir elements distribu-
tion, we assessed 3 sections containing the nucleus. The
positive elements were investigated within 3 main subdi-
visions: the ventral part (PaV); the lateral magnocellular
part (PaLM) and the anterior parvicellular part (PaAP).
Positive neurons were identified for the presence of clearly
labeled cell body and proximal processes. Manual cell
counting was performed with a Leitz Laborlux micro-
scope, equipped with a camera lucida, by using ×10 objec-
tive. Within the BST we observed the presence of positive
cells with a different intensity of the cytoplasmatic immu-
nostaining (the nucleus was always unstained). We have
therefore subjectively classified as clear cells those exhib-
iting a cytoplasmic weak signal, whereas the other ele-
ments characterized by an intense cytoplasmic staining
were classified as dark cells (Fig. 5). This subjective crite-
rion was confirmed by density analysis performed on a
few samples utilizing optical density measurement with
Image J program on digitized images. This analysis dem-
onstrated that neurons classified as dark cells show an
intensity of the reaction at least double than those classi-
fied as weak cells.
For each level of the analyzed nuclei we selected a frame
with a standardized area (500,000 μm2 for MPA; 140,000
μm2 for BSTmpm, BSTmv and VMHvl; 120,000 μm2 for
each subdivision of the PVN; 110,000 μm2 for Arc;
540,000 μm2 for CPu) and counted the immunoreactive
cells within this frame (Fig. 3).
To detect changes in the nNOS-ir cell number during the
female cycle and in comparison to males, we performed a
two-way mixed ANOVA with cycle phase plus males as
between subjects variable and anterior-posterior level as
within subject (repeated) variable. When we detected the
presence of a significant effect of the interaction phase-
level we performed a separate one-way ANOVA for each
level. When preliminary analyses revealed no significant
effects of anterior-posterior levels, the level was collapsed
and the average number (calculated using the average val-
ues from two sections) was analyzed with 1-way ANOVA.
Differences were considered statistically significant for
values of p < 0.05. These analyses were followed, when
appropriate, by Fisher PLSD test, using the software
Statview 5.0 (Abacus Concepts, Berkely, CA, USA).
Sections were photographed with a Zeiss Axioplan I
microscope, equipped with a Nikon Coolpix 990 digital
photocamera connected to an Apple G4 Macintosh. Dig-
ital images were processed using Adobe Photoshop 7.0
(Adobe Systems Incorporated, San Jose, CA, USA).
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